Annual Retained Earnings
-$521.14 M
-$43.19 M-9.04%
December 31, 2024
Summary
- As of March 10, 2025, KNSA annual retained earnings is -$521.14 million, with the most recent change of -$43.19 million (-9.04%) on December 31, 2024.
- During the last 3 years, KNSA annual retained earnings has risen by +$154.25 million (+22.84%).
- KNSA annual retained earnings is now -1894.81% below its all-time high of -$26.13 million, reached on December 31, 2016.
Performance
KNSA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$521.14 M
-$8.89 M-1.74%
December 31, 2024
Summary
- As of March 10, 2025, KNSA quarterly retained earnings is -$521.14 million, with the most recent change of -$8.89 million (-1.74%) on December 31, 2024.
- Over the past year, KNSA quarterly retained earnings has stayed the same.
- KNSA quarterly retained earnings is now -472.70% below its all-time high of -$91.00 million, reached on December 31, 2017.
Performance
KNSA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
KNSA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | 0.0% |
| 3 y3 years | +22.8% | +22.8% |
| 5 y5 years | -46.4% | -46.4% |
KNSA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.0% | +22.8% | -9.0% | +27.7% |
| 5 y | 5-year | -46.4% | +22.8% | -46.4% | +27.7% |
| alltime | all time | -1894.8% | +22.8% | -472.7% | +27.7% |
Kiniksa Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$521.14 M(+9.0%) | -$521.14 M(+1.7%) |
| Sep 2024 | - | -$512.25 M(+2.5%) |
| Jun 2024 | - | -$499.56 M(+0.8%) |
| Mar 2024 | - | -$495.65 M(+3.7%) |
| Dec 2023 | -$477.95 M(-2.9%) | -$477.95 M(-5.0%) |
| Sep 2023 | - | -$503.19 M(+2.8%) |
| Jun 2023 | - | -$489.33 M(-3.0%) |
| Mar 2023 | - | -$504.30 M(+2.5%) |
| Dec 2022 | -$492.03 M(-27.1%) | -$492.03 M(-0.9%) |
| Sep 2022 | - | -$496.50 M(-31.1%) |
| Jun 2022 | - | -$720.59 M(+2.9%) |
| Mar 2022 | - | -$700.61 M(+3.7%) |
| Dec 2021 | -$675.40 M | -$675.40 M(+5.7%) |
| Sep 2021 | - | -$639.06 M(+5.0%) |
| Jun 2021 | - | -$608.52 M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -$566.96 M(+9.6%) |
| Dec 2020 | -$517.47 M(+45.3%) | -$517.47 M(+11.6%) |
| Sep 2020 | - | -$463.82 M(+10.4%) |
| Jun 2020 | - | -$419.98 M(+9.8%) |
| Mar 2020 | - | -$382.51 M(+7.4%) |
| Dec 2019 | -$356.09 M(+83.3%) | -$356.09 M(+9.8%) |
| Sep 2019 | - | -$324.30 M(+9.1%) |
| Jun 2019 | - | -$297.24 M(+14.3%) |
| Mar 2019 | - | -$260.05 M(+33.9%) |
| Dec 2018 | -$194.22 M(+113.4%) | -$194.22 M(+28.1%) |
| Sep 2018 | - | -$151.65 M(+19.2%) |
| Jun 2018 | - | -$127.24 M(+18.9%) |
| Mar 2018 | - | -$106.98 M(+17.6%) |
| Dec 2017 | -$91.00 M(+248.3%) | -$91.00 M |
| Dec 2016 | -$26.13 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual retained earnings year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly retained earnings year-on-year change?
What is Kiniksa Pharmaceuticals annual retained earnings?
The current annual retained earnings of KNSA is -$521.14 M
What is the all time high annual retained earnings for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual retained earnings is -$26.13 M
What is Kiniksa Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, KNSA annual retained earnings has changed by -$43.19 M (-9.04%)
What is Kiniksa Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of KNSA is -$521.14 M
What is the all time high quarterly retained earnings for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly retained earnings is -$91.00 M
What is Kiniksa Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, KNSA quarterly retained earnings has changed by $0.00 (0.00%)